SLB Q3 Beat Signals Recovery, Reshaping Buy Case
Read source articleWhat happened
SLB delivered a strong Q3 with EPS and revenue beats, sequential margin recovery, and robust performance across business units and geographies, alleviating the Q1 2026 disruptions that had pressured the thesis. Management now forecasts durable mid-single-digit global activity growth through 2027, with potential EBITDA of $8.2 billion if Middle East activity accelerates, suggesting the multi-year upcycle is intact. The Seeking Alpha article rates SLB a buy, arguing that inventory rebuilding and energy security demand support a sustained recovery. This contrasts with the earlier DeepValue rating of WAIT, which had awaited proof that Middle East disruption, Well Construction pricing pressure, and OneSubsea startup drag were easing. The Q3 results appear to provide that proof, with sequential margin expansion and broad-based strength.
Implication
Investors should consider the Q3 beat as evidence that the earlier margin and growth concerns were transient, positioning SLB for a rerating toward the bull scenario implied value of $56 if current momentum persists. However, the stock's current price around $47 still sits between the base ($48) and bull ($56) scenarios, leaving limited upside unless multiple expansion or further EBITDA growth materializes. The buy thesis now hinges on sustained Middle East recovery and continued Digital/offshore execution, with the next key checkpoint being Q4 and 2027 guidance for confirmation of the mid-single-digit growth trajectory. Risk remains from oil price weakness toward EIA's $65/bbl forecast, which could compress upstream budgets and reintroduce margin pressure, so a pullback toward the $42 attractive entry or further proof of EBITDA margin above 21.5% would improve risk/reward. For long-term investors, the international and offshore mix, ChampionX accretion, and Digital recurring revenue provide a durable base to own through cycle, but patience is required as the recovery unfolds over multiple quarters.
Thesis delta
Prior thesis was WAIT, expecting margin repair and recovery but requiring proof that Middle East disruption, pricing pressure, and OneSubsea drag were easing. Q3 results with EPS/revenue beats, sequential margin expansion, and robust performance across units indicate these headwinds have begun to abate, shifting the probability weight from base toward bull. The thesis now leans positive, supporting a BUY rating, but conviction is tempered by valuation and the need to confirm sustainability in Q4.
Confidence
Moderate-High